Cargando…

Preclinical characterization of tyrosine kinase inhibitor-based targeted therapies for neuroendocrine thyroid cancer

Medullary thyroid carcinoma (MTC) is a slow growing neuroendocrine (NE) tumor for which few treatment options are available. Its incidence is rising and mortality rates have remained unchanged for decades. Increasing the repertoire of available treatments is thus crucial to manage MTC progression. S...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pozo, Karine, Zahler, Stefan, Ishimatsu, Keisuke, Carter, Angela M., Telange, Rahul, Tan, Chunfeng, Wang, Shuaijun, Pfragner, Roswitha, Fujimoto, Junya, Grubbs, Elizabeth Gardner, Takahashi, Masaya, Oltmann, Sarah C., Bibb, James A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6340867/ https://www.ncbi.nlm.nih.gov/pubmed/30701022 http://dx.doi.org/10.18632/oncotarget.26480

Ejemplares similares

Breaking Bad: how does a neuronal protein cause neuroendocrine cancer?
por: Pozo, Karine, et al.
Publicado: (2013)

Chromogranin A and Its Fragments as Regulators of Small Intestinal Neuroendocrine Neoplasm Proliferation
por: Giovinazzo, Francesco, et al.
Publicado: (2013)

Cdk5 drives formation of heterogeneous pancreatic neuroendocrine tumors
por: Carter, Angela M., et al.
Publicado: (2021)

A water soluble tri-cationic porphyrin–EDTA conjugate induces apoptosis in human neuroendocrine tumor cell lines
por: Schwach, Gert, et al.
Publicado: (2012)

Activation of the ileal neuroendocrine tumor cell line P-STS by acetylcholine is amplified by histamine: role of H3R and H4R
por: Pfanzagl, Beatrix, et al.
Publicado: (2017)

Gene Network Inference and Biochemical Assessment Delineates GPCR Pathways and CREB Targets in Small Intestinal Neuroendocrine Neoplasia
por: Drozdov, Ignat, et al.
Publicado: (2011)

The neuroendocrine phenotype, genomic profile and therapeutic sensitivity of GEPNET cell lines
por: Hofving, Tobias, et al.
Publicado: (2018)

The neuroendocrine phenotype, genomic profile and therapeutic sensitivity of GEPNET cell lines
por: Hofving, Tobias, et al.
Publicado: (2018)

Differential expression of cell cycle regulators in CDK5-dependent medullary thyroid carcinoma tumorigenesis
por: Pozo, Karine, et al.
Publicado: (2015)

Molecular evidence for the bi-clonal origin of neuroendocrine tumor derived metastases
por: Rinner, Beate, et al.
Publicado: (2012)

Cdk5 Modulates Long-Term Synaptic Plasticity and Motor Learning in Dorsolateral Striatum
por: Hernandez, Adan, et al.
Publicado: (2016)

Histamine via histamine H1 receptor enhances the muscarinic receptor‐induced calcium response to acetylcholine in an enterochromaffin cell model
por: Pfanzagl, Beatrix, et al.
Publicado: (2022)

Preclinical Models of Neuroendocrine Neoplasia
por: Sedlack, Andrew J. H., et al.
Publicado: (2022)

Management of Gastrointestinal Neuroendocrine Tumors
por: Wang, Rongzhi, et al.
Publicado: (2019)

Clinical and Preclinical Advances in Gastroenteropancreatic Neuroendocrine Tumor Therapy
por: Crabtree, Judy S.
Publicado: (2017)

Establishment of preclinical chemotherapy models for gastroenteropancreatic neuroendocrine carcinoma
por: Ohmoto, Akihiro, et al.
Publicado: (2018)

Identifying a missing lineage driver in a subset of lung neuroendocrine tumors
por: Pozo, Karine, et al.
Publicado: (2018)

Correction: Establishment of preclinical chemotherapy models for gastroenteropancreatic neuroendocrine carcinoma
por: Ohmoto, Akihiro, et al.
Publicado: (2019)

Transcriptomic Profiling of In Vitro Tumor-Stromal Cell Paracrine Crosstalk Identifies Involvement of the Integrin Signaling Pathway in the Pathogenesis of Mesenteric Fibrosis in Human Small Intestinal Neuroendocrine Neoplasms
por: Laskaratos, Faidon-Marios, et al.
Publicado: (2021)

The dichloromethane fraction of Stemona tuberosa Lour inhibits tumor cell growth and induces apoptosis of human medullary thyroid carcinoma cells
por: Li, ZengXia, et al.
Publicado: (2007)

Cultivation and Immortalization of Human B-Cells Producing a Human Monoclonal IgM Antibody Binding to MDA-LDL: Further Evidence for Formation of Atherogenic MDA-LDL Adducts in Humans In Vivo
por: Tatzber, Franz, et al.
Publicado: (2017)

Anti-tumor effects of shikonin derivatives on human medullary thyroid carcinoma cells
por: Hasenoehrl, Carina, et al.
Publicado: (2017)

Targeted therapy of gastroenteropancreatic neuroendocrine tumours: preclinical strategies and future targets
por: Aristizabal Prada, E T, et al.
Publicado: (2017)

The Stimulatory Adenosine Receptor ADORA2B Regulates Serotonin (5-HT) Synthesis and Release in Oxygen-Depleted EC Cells in Inflammatory Bowel Disease
por: Damen, Rikard, et al.
Publicado: (2013)

Correction: The Stimulatory Adenosine Receptor ADORA2B Regulates Serotonin (5-HT) Synthesis and Release in Oxygen-Depleted EC Cells in Inflammatory Bowel Disease
por: Dammen, Rikard, et al.
Publicado: (2013)

Preclinical Evaluation of Novel Tyrosine-Kinase Inhibitors in Medullary Thyroid Cancer
por: Saronni, Davide, et al.
Publicado: (2022)

Anaplastic lymphoma kinase (ALK)-expressing Lung Adenocarcinoma with Combined Neuroendocrine Component or Neuroendocrine Transformation: Implications for Neuroendocrine Transformation and Response to ALK-tyrosine Kinase Inhibitors
por: Sim, Jongmin, et al.
Publicado: (2018)

Faulty Metabolism: A Potential Instigator of an Aggressive Phenotype in Cdk5-dependent Medullary Thyroid Carcinoma
por: Gupta, Priyanka, et al.
Publicado: (2023)

The avian chorioallantoic membrane as an alternative tool to study medullary thyroid cancer
por: Ghaffari-Tabrizi-Wizsy, Nassim, et al.
Publicado: (2019)

Anti-SSTR2 Antibody-drug Conjugate for Neuroendocrine Tumor Therapy
por: Si, Yingnan, et al.
Publicado: (2020)

L-tyrosine improves neuroendocrine function in a mouse model of chronic stress
por: Wang, Zhihua, et al.
Publicado: (2012)

Preclinical Evaluation of the Multiple Tyrosine Kinases Inhibitor Anlotinib in Leukemia Stem Cells
por: Jiang, Yuelong, et al.
Publicado: (2022)

Comparative genomics of high grade neuroendocrine carcinoma of the cervix
por: Hillman, R. Tyler, et al.
Publicado: (2020)

Neuroendocrine Differentiation in Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor
por: Chang, Youjin, et al.
Publicado: (2013)

Long-term surgical outcomes of gastric neuroendocrine carcinoma and mixed neuroendocrine-non-neuroendocrine neoplasms
por: Iwasaki, Kenichi, et al.
Publicado: (2022)

Preclinical assesement of survivin and XIAP as prognostic biomarkers and therapeutic targets in gastroenteropancreatic neuroendocrine neoplasia
por: Dizdar, Levent, et al.
Publicado: (2016)

Small cell carcinoma of the kidney treated with immune checkpoint inhibitor/tyrosine kinase inhibitor
por: Harada, Mirii, et al.
Publicado: (2023)

Bruton’s Tyrosine Kinase Inhibitors (BTKIs): Review of Preclinical Studies and Evaluation of Clinical Trials
por: Rozkiewicz, Dariusz, et al.
Publicado: (2023)

Exposure to mild blast forces induces neuropathological effects, neurophysiological deficits and biochemical changes
por: Hernandez, Adan, et al.
Publicado: (2018)

Correction to: Exposure to mild blast forces induces neuropathological effects, neurophysiological deficits and biochemical changes
por: Hernandez, Adan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_m136s8bb0mnuf71b3v1sjfbdm8